Drug class profile · refreshed daily from federal data

Barbiturate

8 molecules in this class, — combined CY2024 Part D spend across — claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.

Last updated 15 Oct 2026

NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily

Class summary at a glance.

Every drug in the Barbiturate class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 8tracked in Part D
CY24 Part D spend: —combined across class
Total Rx claims: —— unique beneficiaries
Generic mfrs (active): 25across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

01

Butal/Apap/Caff

— Part D claims (CY24) · First FDA approval: 2023-03-14

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

0%

of class CY24 spend

View profile →

02

Butal/Apap/Caffeine

— Part D claims (CY24) · First FDA approval: 2025-01-02

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

0%

of class CY24 spend

View profile →

03

Butalbital and Acetaminophen

Brand: ALLZITAL · — Part D claims (CY24) · First FDA approval: 1999-06-03

8 generic mfrs 27 plans require PA

Low NADAC$0.571

→

Avg plan cost$0.672

Part D spend — 1× spread, current vs floor

Class share

0%

of class CY24 spend

View profile →

04

Butalbital and Acetaminophen Tablets

Brand: Butalbital and Acetaminophen · — Part D claims (CY24) · First FDA approval: 2017-06-19

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

0%

of class CY24 spend

View profile →

05

Butalbital, Acetaminophen and Caffeine

— Part D claims (CY24) · First FDA approval: 1987-01-21

15 generic mfrs 83 plans require PA

Low NADAC$0.122

→

Avg plan cost$0.726

Part D spend — 6× spread, current vs floor

Class share

0%

of class CY24 spend

View profile →

06

Butalbital, Acetaminophen, Caffeine and Codeine

— Part D claims (CY24) · First FDA approval: 2004-07-01

2 generic mfrs 46 plans require PA

Low NADAC$0.798

→

Avg plan cost$2.30

Part D spend — 3× spread, current vs floor

Class share

0%

of class CY24 spend

View profile →

07

Butalbital, Acetaminophen, and Caffeine Capsules

Brand: Butalbital, Acetaminophen, and Caffeine · — Part D claims (CY24) · First FDA approval: 2019-12-17

Brand-only (no generics)

Low NADAC$0.316

→

Avg plan cost$0.316

Part D spend — 1× spread, current vs floor

Class share

0%

of class CY24 spend

View profile →

08

Butalbital/Acetaminophen/Caffeine

— Part D claims (CY24) · First FDA approval: 2023-01-03

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend —

Class share

0%

of class CY24 spend

View profile →

Related questions.

Q&A librarySourced · reviewed quarterly

pricingWhat is NADAC?pricingIs NADAC the same as my PBM cost?pricingWhat is spread pricing?pricingWhat is a NADAC pass-through PBM contract?pricingWhat's the difference between AWP, MAC, and NADAC?pricingWhat is a dispensing fee in a PBM contract?

Browse all canonical questions →